17409-41-5 Usage
Uses
Used in Pharmaceutical Industry:
Glycolamide, N,N-bis(2-hydroxyethyl)is used as a chelating agent for metal ion complexation reactions, which is crucial in stabilizing certain pharmaceutical formulations and enhancing their efficacy.
Used in Cosmetics Industry:
In the cosmetics industry, Glycolamide, N,N-bis(2-hydroxyethyl)serves as a key component in the development of various cosmetic products, leveraging its ability to form stable complexes and improve the solubility and bioavailability of active ingredients.
Used in Polymer Industry:
Glycolamide, N,N-bis(2-hydroxyethyl)is utilized as a building block in the synthesis of polymers, contributing to the creation of materials with specific properties tailored for various applications.
Used in Drug Delivery Systems:
Glycolamide, N,N-bis(2-hydroxyethyl)is employed in drug delivery systems to enhance the solubility and bioavailability of certain drugs, potentially improving their therapeutic effects and reducing side effects.
Overall, Glycolamide, N,N-bis(2-hydroxyethyl)is a multifaceted chemical compound with a wide range of applications across different industries, particularly in pharmaceuticals, cosmetics, and polymers, due to its unique properties and capabilities.
Check Digit Verification of cas no
The CAS Registry Mumber 17409-41-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,4,0 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 17409-41:
(7*1)+(6*7)+(5*4)+(4*0)+(3*9)+(2*4)+(1*1)=105
105 % 10 = 5
So 17409-41-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO4/c8-3-1-7(2-4-9)6(11)5-10/h8-10H,1-5H2
17409-41-5Relevant academic research and scientific papers
Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides
Daryaee, Fereidoon,Kobarfard, Farzad,Khalaj, Ali,Farnia, Parisa
experimental part, p. 289 - 295 (2009/04/07)
On the basis of the structural similarity of N-substituted glycolamides with N-glycolyl muramic acid residues of the cell wall of Mycobacterium tuberculosis, a series of these compounds were designed and synthesized by the reaction of glycolic acid acetonide 1 (2,2-dimethyl-5-oxo-1,3-dioxolane) with the proper amines. The minimum inhibitory concentration (MIC) was determined against M. tuberculosis H37Rv in BACTEC 12B medium, using the Microplate Alamar Blue Assay (MABA). Among the synthesized compounds, all those with disubstituted amide structure accompanied by one or two heteroatom(s) with loan pair(s) of electrons atom(s) β to the amide nitrogen demonstrated moderate anti-tuberculosis activity and all the monosubstituted amides showed no activity at all.
